JS-K is reported to overcome MDR to enhance metallotherapy36 and reversal of drug resistance in human MDR tumor cells37 Thymosin β10 (TMSB10) has been demonstrated to be overexpressed and function as an oncogene in most types of human cancer including HCC38. Here, TMSB10 is linked to neoplasm.